EUVIMEDEUVIMED entdecken
Crossref

Amino Acid PET in Neurooncology

Norbert Galldiks, Philipp Lohmann, Gereon R Fink, Karl-Josef Langen

Journal of Nuclear Medicine · 2023-05 · 64 (5) · 693-700

DOI: 10.2967/jnumed.122.264859 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 13.04.2023. Verfasst von Norbert Galldiks und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany; norbert.galldiks@uk-koeln.de. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 140 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For decades, several amino acid PET tracers have been used to optimize diagnostics in patients with brain tumors. In clinical routine, the most important clinical indications for amino acid PET in brain tumor patients are differentiation of neoplasm from nonneoplastic etiologies, delineation of tumor extent for further diagnostic and treatment planning (i.e., diagnostic biopsy, resection, or radiotherapy), differentiation of treatment-related changes such as pseudoprogression or radiation necrosis after radiation or chemoradiation from tumor progression at follow-up, and assessment of response to anticancer therapy, including prediction of patient outcome. This continuing education article addresses the diagnostic value of amino acid PET for patients with either glioblastoma or metastatic brain cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGlioblastomaHumansAmino AcidsPositron-Emission TomographyBiopsyTyrosine

Stichwörter der Autor:innen

FDOPAFETMETfluciclovine

Substanzen

Amino AcidsTyrosine

Autor:innen und Institutionen

  • Department of Neurology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany; norbert.galldiks@uk-koeln.de.
  • Institute of Neuroscience and Medicine, Research Center Juelich, Juelich, Germany.
  • Center for Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany; and.
  • Department of Neurology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Department of Nuclear Medicine, RWTH University Hospital Aachen, Aachen, Germany.

Zitieren

APA

Galldiks, N., Lohmann, P., Fink, G. R., & Langen, K. J. (2023). Amino Acid PET in Neurooncology. Journal of Nuclear Medicine, 64(5), 693-700. https://doi.org/10.2967/jnumed.122.264859

Vancouver

Galldiks N, Lohmann P, Fink GR, Langen KJ. Amino Acid PET in Neurooncology. Journal of Nuclear Medicine. 2023;64(5):693-700. doi:10.2967/jnumed.122.264859

BibTeX
@article{Galldiks2023,
  author = {Galldiks, Norbert and Lohmann, Philipp and Fink, Gereon R and Langen, Karl-Josef},
  title = {Amino Acid PET in Neurooncology},
  journal = {Journal of Nuclear Medicine},
  year = {2023},
  volume = {64},
  number = {5},
  pages = {693--700},
  doi = {10.2967/jnumed.122.264859}
}
Kostenlos starten →